Transgenic Mice as a Source of Fully Human Antibodies for the Treatment of Cancer

Author： Davis C.G. Gallo M.L. Corvalan J.R.F.

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.18, Iss.4, 1999-12, pp. : 421-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice

By Machlenkin Arthur Azriel-Rosenfeld Ronit Volovitz Ilan Vadai Ezra Lev Avital Paz Adrian Goldberger Ofir Reiter Yoram Tzehoval Esther Benhar Itai Eisenbach Lea

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 217-226

Springer Publishing Company

Access to resources Recommend Favorite

TRAIL-receptor antibodies as a potential cancer treatment

By Buchsbaum Donald J Forero-Torres Andres LoBuglio Albert F

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 405-409

Future Medicine

Access to resources Recommend Favorite

Effect of Melatonin and Linolenic Acid on Mammary Cancer in Transgenic Mice with c-neu Breast Cancer Oncogene

By Rao G.N. Ney E. Herbert R.A.

Breast Cancer Research and Treatment, Vol. 64, Iss. 3, 2000-12 ,pp. : 287-296

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor Necrosis Factor (TNF-a) Antibodies in the Treatment of Renal Cell Cancer

By Maisey Nick

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 589-593

Informa Healthcare

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite